Peter J. Kushner's Insider Trades & SAST Disclosures
Peter J. Kushner's most recent trade in Olema Pharmaceuticals Inc was a trade of 61,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter J. Kushner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | Peter J. Kushner | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 61,750 | 61,750 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | 23 Nov 2020 | 228,761 | 1,301,513 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | 23 Nov 2020 | 228,761 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | 23 Nov 2020 | 130,159 | 1,431,672 | - | - | Common Stock | ||
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | 23 Nov 2020 | 130,159 | 0 | - | - | Series A-1 Convertible Preferred Stock | ||
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 179,340 | 179,340 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Peter J. Kushner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 143,472 | 1,072,752 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges